Duoning Biotechnology, a Chinese biotech firm that focuses on providing serum-free cell culture medium, has raised nearly RMB100 million (US$14.88 million) in a series A+ round of financing, according to a statement released on Thursday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?